Radiopharmaceutical Imaging and Dosimetry, LLC (Rapid)

About Radiopharmaceutical Imaging and Dosimetry, LLC (Rapid)

Radiopharmaceutical Imaging and Dosimetry, LLC (Rapid) operates in the Software & AI space and is among the firms Bracken expects to track at SNMMI 2026.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• FierceBiotech · 2026-07-02
  Radiopharmaceutical Imaging And Dosimetry Llc Rapid appoints new Chief Medical Officer ahead of pivotal trial
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• BioPharma Reporter · 2026-12-21
  Radiopharmaceutical Imaging And Dosimetry Llc Rapid signs supply agreement to support late-stage trials
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Reuters Health · 2026-01-28
  Radiopharmaceutical Imaging And Dosimetry Llc Rapid expands cyclotron capacity to meet Lu-177 demand
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Endpoints News · 2026-10-23
  Radiopharmaceutical Imaging And Dosimetry Llc Rapid announces Phase II readout for lead theranostic candidate
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.